Republic Act 7581, otherwise known a the œPrice Act  states, among other things that, œIt is policy of the state to ensure the availability of basic necessities and prime commodities at reasonable prices at all times x x x œ.

For the proper implementation of the above policy, with respect to pharmaceutical products, and consistent with the provisions of R.A. 7394 the œConsumer Act  and R.A. 3720 the Foods, Drugs, Devices and Cosmetics Act , the Bureau of Food and Drugs is hereby ordered to require the submission of a declaration of the œsuggested retail price  of pharmaceutical products by the registrant as an additional requirement for product registration, an addendum to Administrative Order 67, s. 1989 œSubject: Requirements for Registration of Pharmaceutical Products .

For purposes of this Administrative Order, Suggested Retail Price is defined as the proposed amount or cost of a pharmaceutical product per unit item when retailer offers this for sale to the consumer or end-user. Furthermore, unit item refers to per tablet or capsule, per ampoule or vial, or per bottle of a liquid formulation, as purchased in a local drug outlet by the consumer.

This Order shall take effect fifteen (15) days after its publication in a newspaper of general circulation.

Adopted: 21 Nov. 1999

(SGD.) ALBERTO G. ROMUALDEZ, JR. MD.
Secretary of Health